Seasonal Variations in the Incidence of Ischemic Stroke, Extracranial and Intracranial Hemorrhage in Atrial Fibrillation Patients.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
25 09 2020
Historique:
pubmed: 31 8 2020
medline: 14 10 2021
entrez: 1 9 2020
Statut: ppublish

Résumé

Ischemic stroke (IS) and major bleeding, which are serious adverse events in patients with atrial fibrillation (AF), could have seasonal variations, but there are few reports.Methods and Results:In the Shinken Database 2004-2016 (n=22,018), 3,581 AF patients (average age, 63.5 years; 2,656 men, 74.2%; 1,388 persistent AF, 38.8%) were identified. Median CHADS Significant seasonal variations were observed for IS, ECH, and ICH events in AF patients, and were consistently the highest in winter. A small peak of ECH was observed in summer, which seemed, in part, to be related to increased DOAC use.

Sections du résumé

BACKGROUND
Ischemic stroke (IS) and major bleeding, which are serious adverse events in patients with atrial fibrillation (AF), could have seasonal variations, but there are few reports.Methods and Results:In the Shinken Database 2004-2016 (n=22,018), 3,581 AF patients (average age, 63.5 years; 2,656 men, 74.2%; 1,388 persistent AF, 38.8%) were identified. Median CHADS
CONCLUSIONS
Significant seasonal variations were observed for IS, ECH, and ICH events in AF patients, and were consistently the highest in winter. A small peak of ECH was observed in summer, which seemed, in part, to be related to increased DOAC use.

Identifiants

pubmed: 32863288
doi: 10.1253/circj.CJ-20-0134
doi:

Substances chimiques

Anticoagulants 0
Warfarin 5Q7ZVV76EI

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1701-1708

Auteurs

Mitsunori Oida (M)

Department of Cardiovascular Medicine, The Cardiovascular Institute.

Shinya Suzuki (S)

Department of Cardiovascular Medicine, The Cardiovascular Institute.

Takuto Arita (T)

Department of Cardiovascular Medicine, The Cardiovascular Institute.

Naoharu Yagi (N)

Department of Cardiovascular Medicine, The Cardiovascular Institute.

Takayuki Otsuka (T)

Department of Cardiovascular Medicine, The Cardiovascular Institute.

Mikio Kishi (M)

Department of Cardiovascular Medicine, The Cardiovascular Institute.

Hiroaki Semba (H)

Department of Cardiovascular Medicine, The Cardiovascular Institute.

Hiroto Kano (H)

Department of Cardiovascular Medicine, The Cardiovascular Institute.

Shunsuke Matsuno (S)

Department of Cardiovascular Medicine, The Cardiovascular Institute.

Yuko Kato (Y)

Department of Cardiovascular Medicine, The Cardiovascular Institute.

Tokuhisa Uejima (T)

Department of Cardiovascular Medicine, The Cardiovascular Institute.

Yuji Oikawa (Y)

Department of Cardiovascular Medicine, The Cardiovascular Institute.

Satoshi Hoshino (S)

Department of Cardiovascular Surgery, The Cardiovascular Institute.

Minoru Matsuhama (M)

Department of Cardiovascular Surgery, The Cardiovascular Institute.

Tatsuya Inoue (T)

Department of Cardiovascular Surgery, The Cardiovascular Institute.

Junji Yajima (J)

Department of Cardiovascular Medicine, The Cardiovascular Institute.

Takeshi Yamashita (T)

Department of Cardiovascular Medicine, The Cardiovascular Institute.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH